501 filings
Page 7 of 26
8-K
5wltz6b 2qh1zsfhil
3 Jan 18
Results of Operations and Financial Condition
12:00am
8-K
ouj6h ilmu0
2 Jan 18
Entry into a Material Definitive Agreement
12:00am
SC TO-T
7yse pu37fie5
29 Dec 17
Third party tender offer statement
12:00am
8-K
jjev731
18 Dec 17
Departure of Directors or Certain Officers
12:00am
8-K
oayzmp6y
18 Dec 17
Departure of Directors or Certain Officers
12:00am
8-K
asfpcj4u s8f
1 Nov 17
Allergan Reports Solid Top-Line Execution in Third Quarter 2017 with 11% Increase in GAAP Net Revenues to $4.03 Billion
12:00am
8-K
f5ey5550g ku1y
25 Sep 17
Departure of Directors or Certain Officers
12:00am
8-K
789szklp m97yrcdo
3 Aug 17
Allergan Reports Continued Strong Execution in Second Quarter 2017 with 9% Increase in GAAP Net Revenues to $4.0 Billion
12:00am
8-K
fouvbnc40kklq7xvk57
21 Jul 17
Departure of Directors or Certain Officers
12:00am
SD
mwrvy ja0kqjy
31 May 17
Conflict minerals disclosure
12:00am
8-K
b21vl9f
26 May 17
Allergan Announces Closing of Public Offering of Senior Notes to
12:00am
8-K
1u1bm ianqjijrq
25 May 17
Allergan Announces Early Tender Results and Upsizing of Tender Offers by Certain Subsidiaries
12:00am
8-K
vm1fm6wc
24 May 17
Allergan Announces Pricing of Public Offering of Senior Notes to Refinance Existing Debt
12:00am
8-K
yxnyvp gt01n3a
23 May 17
Allergan Announces Commencement of Proposed Public Offering of
12:00am
8-K
nsjc hei6skz8a3u
10 May 17
Allergan Announces Tender Offers by Certain Subsidiaries
12:00am
S-8
17x7qu hqk0s
9 May 17
Registration of securities for employees
12:00am
8-K
o9g xbz2oo
9 May 17
Allergan Reports Solid Start to 2017 with 5% Increase in First Quarter GAAP Net Revenues to $3.6 Billion
12:00am